This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
David Wei, PhD
Advertisement
Articles by David Wei, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
Lilly Prepares for Retatrutide FDA Filing Following Additional Phase 3 Data in Diabetes, CVD
3
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
4
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
5